Measurement-to-measurement blood pressure variability is related to cognitive performance: The Maine-Syracuse Study by Crichton, Georgina E. et al.
The University of Maine
DigitalCommons@UMaine
Maine-Syracuse Longitudinal Papers Maine-Syracuse Longitudinal Study
2014
Measurement-to-measurement blood pressure
variability is related to cognitive performance: The
Maine-Syracuse Study
Georgina E. Crichton
University of South Australia
Merrill F. Elias
University of Maine, mfelias@maine.edu
Gregory A. Dore
National Institute on Aging
Rachael V. Torres
University of Maine
Michael A. Robbins
University of Maine, michael.robbins@umit.maine.edu
Follow this and additional works at: https://digitalcommons.library.umaine.edu/
longitudinal_papers
This Article is brought to you for free and open access by DigitalCommons@UMaine. It has been accepted for inclusion in Maine-Syracuse
Longitudinal Papers by an authorized administrator of DigitalCommons@UMaine. For more information, please contact
um.library.technical.services@maine.edu.
Repository Citation
Crichton, Georgina E.; Elias, Merrill F.; Dore, Gregory A.; Torres, Rachael V.; and Robbins, Michael A., "Measurement-to-
measurement blood pressure variability is related to cognitive performance: The Maine-Syracuse Study" (2014). Maine-Syracuse
Longitudinal Papers. 31.
https://digitalcommons.library.umaine.edu/longitudinal_papers/31
MEASUREMENT-TO-MEASUREMENT BLOOD PRESSURE
VARIABILITY IS RELATED TO COGNITIVE PERFORMANCE: THE
MAINE-SYRACUSE STUDY
Georgina E. Crichtona,b,*, Merrill F. Eliasc,d, Gregory A. Doree, Rachael V. Torresc, and
Michael A. Robbinsc,d
1Nutritional Physiology Research Centre, University of South Australia, Adelaide, Australia
2Centre de Recherche Public Santé, Centre d’Etudes en Santé, Grand-Duchy of Luxembourg
3Department of Psychology, University of Maine, Orono, Maine, USA
4Graduate School of Biomedical Sciences and Engineering, University of Maine, Orono, Maine,
USA
5Behavioral Epidemiology Section, Laboratory of Epidemiology and Population Sciences,
National Institute on Aging, National Institutes of Health, Baltimore, USA
Abstract
The objective was to investigate the association between variability in blood pressure and
cognitive function for sitting, standing and reclining blood pressure values, and variability derived
from all 15 measures. In previous studies only sitting blood pressure values have been examined,
and only a few cognitive measures have been employed. A secondary objective was to examine
associations between blood pressure variability and cognitive performance in hypertensive
individuals stratified by treatment success. Cross-sectional analyses were performed on 972
participants of the Maine Syracuse Study for whom 15 serial blood pressure clinic measures (5
sitting, 5 recumbant and 5 standing) were obtained, prior to testing of cognitive performance.
Using all 15 measures, higher variability in systolic and diastolic blood pressure was associated
with poorer performance on multiple measures of cognitive performance, independent of
demographic factors, cardiovascular risk factors, and pulse pressure. When sitting, reclining and
standing systolic blood pressure values were compared, only variability in standing blood pressure
was related to measures of cognitive performance. However, for diastolic blood pressure,
variability in all three positions was related to cognitive performance. Mean blood pressure values
were weaker predictors of cognition. Furthermore, higher overall variability in both systolic and
diastolic blood pressure was associated with poorer cognitive performance in unsuccessfully
treated hypertensive individuals (with blood pressure ≥140/90 mmHg), but these associations were
not evident in those with controlled hypertension.
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Introduction
Measures of blood pressure (BP) in the office or clinic are typically used to assess an
individuals risk for BP-related cardiovascular events, diagnose hypertension, and
subsequently guide the need for antihypertensive drugs.1 However, variability in BP
measures is being increasingly recognized as a potentially important consideration in risk
prediction for stroke and vascular events.1–3 Less is known about the relationship between
BP variability and cognitive function. Given that BP variability has been associated with
lower hippocampal volume, the presence of cerebral microbleeds and cortical infarcts,4 and
white matter hyperintensities,5,6 it is important to examine relations between BP variability
and cognitive performance.
Reviews of the literature indicate that BP averaged over multiple BP assessments is
associated with lower cognitive performance and dementia.7,8 More recently, studies
suggest that higher BP variability may be associated with poorer cognitive function4,9–11
and risk of dementia.11,12 These studies have used a single screening measure to assess
cognitive function, such as the Mini-Mental State Examination (MMSE),13 have based their
variability indicators on only few BP measures, or have used ambulatory BP measures with
measurements taken throughout the day and/or night.9,10,14 Despite the advantages of
ambulatory BP, the practice of office-type measurements and other non-ambulatory
measurements in research will continue. Guidelines for treatment of hypertension emphasize
multiple BP assessments, in a number of different positions.15 However, even if the arm of
the patient is placed at the correct ‘heart’ level,15 the assumption that BP in sitting and
supine assessment can be considered similar is incorrect.16,17 Further, correlations between
office BP with ambulatory BP may vary according to office position.18
We are unaware of any studies that have investigated whether or not relations between
variability in BP and cognitive function differ according to the position in which BP is
measured, namely sitting, reclining and standing. Given the increasing recognition of
variability in BP as a stronger predictor for vascular events than average BP, we are also
interested in examining whether variability is superior to mean BP assessment in predicting
cognitive performance for multiple cognitive domains of functioning.
In a recent paper in Hypertension, Matsumoto et al.9 followed 486 participants from the
Ohshama study, a community-based study of Japanese individuals over a median of 7.8
years using a single measure of cognitive ability, the MMSE. Day-to-day variability in
systolic BP was significantly associated with cognitive decline at follow-up (increased risk
of 51%), and this was true after adjustment for demographic factors, cardiovascular risk
factors and pulse pressure. However, these investigators did not report findings for diastolic
BP, a goal of the present study. More importantly, Matusumato et al.9 found no associations
between variabiliy in BP and MMSE scores within treated hypertensives. This may have
been because the MMSE is less sensitive to cognitive performance in higher performing
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individuals who do not have clinical cognitive deficits, or because treated hypertensives
were not stratified by those who were successfully treated and those who were not. We are
unaware of any study that has examined variability in BP with cognitive performance for
successfully and unsuccessfully treated hypertensive individuals.
The Maine Syracuse Longitudinal Study (MSLS) provides a good data set for this study
because participants underwent multiple BP measurements and cognitive assessment at each
wave of the study and all hypertensive individuals (BP in excess of 140/90) were referred to
their own physician for treatment as usual. Thus we are able to compare those who were
successfully and unscuccessfully treated.
We hypothesized that variability in both systolic and diastolic BP would be related to poorer
performance in multiple cognitive domains using values obtained from 5 sitting, 5
recumbent and 5 standing assessments and an overall variability score obtained from all 15
BP measures would be inversely related to cognitive performance. We hypothesized that
variability in performance would be related to cognitive function only for those for whom
BP was not normalized by medication, and finally that mean systolic and diastolic BP would
show weaker relations with cognitive performance than variability in BP based on the same
number of BP assessments.
Methods
Participants
Subjects were community-dwelling individuals participating in the 6th wave of the Maine
Syracuse Study (MSLS), conducted in central New York. Details of initial study recruitment
have been previously described.19–22 Volunteers for studies of aging were recruited by
various forms of public announcements including media. Those with diagnosed alcoholism
and psychiatric disorder were not admitted to the study. Participants for the present study
were those who completed a comprehensive assessment of cognition (2001–2006) and
where data on a broad array of cardiovascular risk factors were obtained by objective
measures (wave 6). From an initial sample of 1049 adults at wave 6, we excluded those
missing data on cardiovascular health (n=34), history of acute stroke (n=28), diagnosis of
probable dementia (n=8), undertaking dialysis treatment (n=5), unable to read English (n=1),
or reporting alcohol abuse (n=1), leaving 972 participants. Dementia, stroke and dialysis
cases were excluded as we were interested in examining relationships between BP and
cognitive performance in people without severe cognitive impairment.
Acute stroke was defined as a focal neurological deficit persisting for >24 hours and
probable dementia was defined by cognitive measures, medical records and a
multidisciplinary dementia review using the National Institute of Neurological Diseases and
Communicative Diseases and Stroke/ Alzheimer's Disease and Related Disorders (NINCDS-
ADRDA) criteria.23 The University of Maine Institutional Review Board approved this
study and informed consent was obtained from all participants.
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Procedure
A blood sample was obtained following fast from midnight. Standard assay methods were
employed to obtain total cholesterol, HDL, LDL, triglycerides, and fasting plasma glucose.
Body weight was measured to the nearest 0.1 kg with participants wearing light clothing,
and height was measured with a vertical ruler to the nearest 0.1 cm. Body mass index (BMI)
was calculated as weight in kilograms divided by height in metres squared (kg/m2).
Smoking status (never, former, current) was based on self-report from the Nutrition and
Health Questionnaire, as was alcohol consumption. Diabetes was defined as fasting glucose
level of ≥126mg/dL, or being treated with anti-diabetic medication.The physical assessment
was followed by a light breakfast and then the neuropsychological examination.
Predictor variables: blood pressure
The BP measurements were taken in the morning after a supine rest for 15 minutes,
following the brief physical examination. Automated BP measures (GE DINAMAP
100DPC-120XEN, GE Healthcare) were taken 5 times each in sitting, reclining, and
standing positions using hospital level instrumentation so as to standardize measurement
procedures. The average (mean) systolic BP and diastolic BP (mmHg) taken from the 5
sitting, standing and reclining measures in each position was calculated, as was the total
mean systolic BP and diastolic BP from all 15 measures. Following the literature, variability
in systolic and diastolic BP were calculated as the standard deviation (SD) of the 5 measures
in each position, and an overall variability score was calculated from all 15 measures. The
mean and SD from the first two sitting BP measures taken were also calculated (both
systolic and diastolic). Pulse pressure (mmHg) was calculated as the difference in mean
systolic BP and mean diastolic BP (taken from 15 measures). Hypertension was defined as
BP of ≥140/90, or taking medications for hypertension. Controlled hypertension (treated
successfully) was defined as those on medication and with BP of <140/90 mmHg, and
uncontrolled hypertension (treated unsuccessfully) as those on medication and with BP of
≥140/90 mmHg. A second criterion of uncontrolled BP (≥135/85 mmHg) employed by
Matsumoto et al,9 was used in a sensitivity analysis.
Dependent variables: cognitive function
Cognitive testing was conducted in the afternoon following a light mid-day lunch and a one
half-hour rest period. The MSLS neuropsychological test battery comprises 18 individual
tests designed to measure a wide range of cognitive abilities. Composite scores have been
developed based on factor analysis and have been used in many previous studies of the
relations between cardiovascular risk factors and cognitive performance.7,19,21,22,24 The four
composite scores are: Visual Spatial Memory and Organization, Scanning and Tracking,
Verbal Episodic Memory, and Working Memory.21 The WAIS Similarities Test,25 a
measure of abstract reasoning, loaded on all composite scores (factors) and was thus
employed separately. The tests used to define each composite and the factor analytic
methods used to derive these composites have been described previously.21 A Global
Cognition Composite score was also derived by averaging the z-scores for all individual
tests in the battery. In addition, the MMSE,13 a global measure of mental status, was
employed.
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Additional predictor variables—Covariables included age (continuous, years), gender,
education (years), ethnicity (African American/other), pulse pressure (mmHg), diabetes
(Y/N), BMI (kg/m2), total cholesterol (mg/dL), smoking (Y/N), and alcohol consumption
(Y/N). This is the covariate set employed by Matsumoto et al.9 in their recent variability
study. Of the risk factors, alcohol consumption and smoking were based on self-report.
Statistical Analyses
First, analyses with t-test comparisons between pairs of means were performed to determine
whether means and variability across the sitting, reclining and standing BP measures
differed (P <0.05). Then, according to the type of variable (continuous or categorical),
independent samples t-tests and Chi-square tests were used to compare demographic, health,
and BP variables, according to hypertension status (controlled versus uncontrolled).
For the primary analyses, the means and variability in systolic and diastolic BP were each
related to the cognitive functioning measures via multiple linear regression analyses. These
analyses were performed in the whole sample (n=972), including persons with normal BP,
and for successfully (n=289) and unsuccessfully treated (medicated) hypertensive individals
(n=195). The following regression covariate sets were used, but findings are reported only
for Covariate set 2 because results were the same for both sets:
Covariate set 1 - Basic: age, gender, education, ethnicity;
Covariate set 2 - Basic + diabetes, pulse pressure, BMI, total cholesterol, smoking
(Y/N), and alcohol consumption (Y/N). Pulse pressure was excluded from the extended
model when testing associations between mean BP and cognitive function. Covariate set
2 was employed in the Matsumoto et al.9 study and each of these variables were related
to the predictors or outcomes in the present study.
All statistical analyses were performed with PASW for Windows® version 21.0 software
(formerly SPSS Statistics Inc. Chicago, Illinois). P<0.05 was considered statistically
significant.
Results
Preliminary analyses
Preliminary analyses indicated higher variability (SD) values for standing than for sitting
and reclining (paired t-tests, all P values <0.001), thus underscoring the importance of
examining sitting, standing and reclining BP associations with cognitive performance
separately. Mean systolic BP in sitting was significantly higher than mean systolic BP in
either reclining or standing (both P<0.001). The mean and variability in systolic and
diastolic BP, taken in each position, can be seen in Online Table S1. However the proportion
of persons with orthostatic hypertension and orthostatic hypotension (4.7% and 3.2%
respectively) were small, and there was no evidence of relations between either with
cognitive function in preliminary analyses.
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Participant characteristics
Table 1 shows the demographic and health characteristics, and BP-related measures of the
sample, according to hypertension control status. Those with controlled hypertension were
younger, had higher education, and had lower variability in both systolic and diastolic BP
(all P<0.05).
Systolic BP and Cognitive Function
Table 2 shows raw regression coefficients, SE and P values summarizing the significant
associations between systolic BP and cognitive performance. Higher variability in systolic
BP (SD) was related significantly to poorer scores on the Global Composite, Visual Spatial
Memory and Organization, Similarities (measure of abstract reasoning), and the MMSE for
all BP measures combined, and for the standing BP assessment (with exception of
Similarities) (all P<0.05). Mean systolic BP was inversely associated with the Global
Composite, Visual Spatial Memory and Organization, and Similarities, taken in standing
only. These associations were significant with full adjustment for demographic,
cardiovascular risk factors, and pulse pressure.
Diastolic BP and Cognitive Function
Overall variability in diastolic BP was significantly and inversely related to the Global
Composite, Visual Spatial Memory and Organization, and Similarities (all P<0.01), shown
in Table 3. It was also related to assessments taken in all three postures for Visual Spatial
Memory and Organization and for Similarities, and for reclining and standing for the Global
Composite score. Relations for sitting BP were in the same direction as the other postures
but did not achieve conventional statistical significance (P=0.08). In contrast to systolic BP,
overall variability in diastolic BP was unrelated to the MMSE, but variability obtained from
the sitting measures was (P<0.05).
Mean diastolic BP taken from all 15 BP measures was inversely associated with the Global
Composite, Visual Spatial Memory and Organization, Similarities, and the MMSE.
Consistent findings across these measures of cognition were only seen when the average of
all BP measures was used. Means taken from sitting, reclining and standing BP values were
seen for three measures, Visual Spatial Memory and Organization, Similarities, and the
MMSE. There were no significant associations between mean BP or variability in BP
(systolic or diastolic) with Verbal Episodic Memory or Working Memory.
BP Variability and Cognitive Performance According to Treatment Status
As shown in Table 4, in those with controlled hypertension, that is, on medication and
treated successfully (n=289), there were no associations between variability in either SBP or
DBP and any cognitive outcome measure (basic or extended models). The pattern of results
for the basic model were the same and thus are not included in this table.
In those with uncontrolled HT, that is, on medication but not treated successfully (n=195),
variability in systolic and diastolic BP were each inversely associated with scores on the
Global Composite and with the Similarities test (all P<0.05, extended model). Diastolic
variability was also inversely related to Visual Spatial Memory and Organization, and
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systolic variability was related to the MMSE. For example, an increase in systolic variability
of 10 SDs was associated with a reduction in MMSE score of 0.7 z-score units.
Mean systolic BP, from all 15 measures, was unrelated to any cognitive outcome (basic or
extended model), in either those with controlled or uncontrolled hypertension (data not
shown). Mean diastolic BP was inversely associated with the Global Composite (b=−.019,
P=.007), Visual Spatial Memory and Organization (b=−.023, P=.002), Similarities (b=−.
018, P=.023), and the MMSE (b=−.024, P=.011), only in those with uncontrolled
hypertension (extended model, pulse pressure excluded from model, data not shown).
Sensitivity Analyses
Sensitivity analyses were further performed using a cut-score of <135/85 for controlled BP
levels (ie. successfully treated), as used by Matsumoto et al.9 The pattern of results seen
when comparing successfully and unsuccessfully controlled hypertension groups was the
same.
To determine whether results for variability would hold with adjustment for mean BP,
analyses were performed replacing pulse pressure with mean systolic or mean diastolic BP
in the extended model. Inverse assocations between overall variability in systolic BP and
scores on Similarities and the MMSE remained significant (both P<0.05). Higher overall
variability in diastolic BP and lower scores on the Global Composite, Visual Spatial
Memory and Organization, and Similarities remained when pulse pressure was replaced
with mean diastolic BP (all P<0.05). The significant findings in those with uncontrolled
hypertension (Table 4) remained unchanged for both systolic and diastolic variability
measures.
We repeated all of the main analyses decribed above using the just the first two assessments
of sitting BP (means and SD of systolic and diastolic BP) following Matsumoto et al.9 with
respect to their office measurements. There were no significant associations between the
predictors (mean and variablity in BP) and cognition based on two BP assessments.
Discussion
We found that variability in BP is associated with poorer cognitive function. These
associations are independent of demographic factors (age, education, sex and ethnicity),
major risk factors for cardiovascular disease, and pulse pressure, or alternatively mean BP.
Consistent with previous findings, variability in BP yields stronger associations with
cognitive performance than mean BP,9,10,12 and in the present study we find that this is true
both for systolic and diastolic BP. A question might be raised as to whether cognitive
performance predicted greater BP variability or mean BP rather than the other way round.
We feel this is unlikely as BP was assessed during the morning session and cognitive
function during the afternoon. Moreover, in ongoing studies of treatment-resistant
hypertension in the MSLS, Torres et al. found no evidence that cognition prospectively
predicted variability in BP or mean BP.26,27
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In the present study, the strongest associations between variability in BP and cognitive
performance were observed for diastolic BP where statistically significant associations were
observed for all measures combined, and for sitting, reclining, and standing BP assessments.
However, variability in systolic BP related to MMSE scores measured in all positions.
Diastolic BP has also been shown to be a stronger predictor of cognitive performance than
averaged systolic pressure,28,29 and this has also been true in the Framingham Heart
Study.30 A parsimonious explanation of stronger and more consistent findings for diastolic
variability in the present study is that diastolic BP is generally a better predictor of cognitive
functioning in samples that vary over a wide range of adult ages and are not focused on the
elderly.3 While systolic BP has been a focus of attention with respect to variability in BP
and cognition,9 it is quite clear that pulsatile variations in diastolic BP and chronic high
diastolic BP have a deleterious influence on the brain and vessel walls via white matter
lesions and atherosclerotic processes and that the small cerebral arteries undergo progressive
vascular atrophy in relation to high levels of diastolic BP.31,32
Our findings support results from the PROspective Study of Pravastatin (PROSPER), where
higher variability in both systolic and diastolic BP over a 3-year period (measured in sitting,
3-monthly) was associated with worse cognitive performance in over 5000 elderly
participants (mean age 75.3 years).4 In analyses adjusted for mean BP and cardiovascular
risk factors, higher visit-to-visit variability in systolic and diastolic BP were associated with
poorer performance on tests of attention, processing speed, immediate and delayed memory,
as well as lower hippocampal volume and cortical infarcts.
The most robust set of relations between variability in BP and mean BP and cognition are
seen when sitting, recumbent and standing BP values were combined into an all
measurements index. It is clear that we are inducing more variability by basing 15 measures
of BP in different postures for the overall measure of variability. However, if variability is a
useful diagnostic tool it would seem that using methods that promote variability is not a
disadvantage, and it is well known that sitting BP has become a ‘time saving’ compromise
between reclining and standing pressures.
Matsumoto et al,9 found that variability in BP was related to cognition only in untreated
individuals. We had too few hypertensive subjects who were untreated to perform a
meaningful analysis for this group but clearly variability in BP is related to cognition in
unsuccessfully treated hypertensive individuals. By wave 6, nearly all participants in the
MSLS with hypertension are treated with medications (80.9%). Those who were untreated
were simply observed futher or treated initially with lifestyle changes. However, we were
able to compare uncontrolled and controlled hypertensive individuals. As hypothesized, in
the MSLS, measures of variability were unrelated to any measure of cognition in the
successfully treated (medicated) individuals, and this was true with two definitions of
successful treatment, BP <140/90 and <135/85, but significant associations between mean
BP and variability in BP were observed in unsuccessfully treated hypertensive individuals.
In an editorial commentary on mechanisms related to variability in day-to-day BP, Palatini33
points out that elevated BP variability may be related to poor adherence to treatment. Thirty
percent of the unsuccessfully medicated hypertensives met the criteria for treatment-resistant
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hypertension (taking 3 or more classes of hypertensive medication) in comparison to 24
percent of the successfully treated (Fisher's exact test, P<0.08). Ninety-one percent of the
unsuccessfully treated hypertensives took their medications each day, as compared to 96
percent of the successfully medicated hypertensive individuals (Fisher's exact test P<0.08).
One may raise a question as to whether better cogntive performance predicted membership
in the successfully treated group. Torres et al.26,27 found that only the Verbal Memory
composite score was positively associated with membership in the controlled hypertension
group. However, none of the cognitive outcomes related to systolic or diastolic BP
variability were predictors of membership in the contolled hypertensive group.
Clinical trials suggest that Angiotensin II blocking agents and angiotensin-converting
enzyme (ACE) inhibitors are related to improved memory performance.34,35 We did not
conduct a controlled clinic trial, did not control for dosage levels, and did not examine
improvment in performance in this crosss-sectional, treatment-as-usual study. However, it is
of interest to note that studies of treatment-resistent hypertension26,27 performed in our wave
6 sample of participants, found that the only class of medication for which cognitive
performance (Global Composite and Working Memory), was above the mean and superior
relative to other classes of medication was the Angiotensin II receptor blocker class. This
was observed only for the controlled hypertensive individuals. The proportion of persons
treated with this antihypertensive medication class was relatively low; 14 percent in the
controlled hypertensives and 10 percent in the uncontrolled hypertensives.
Regardless of why successful hypertension management was not achieved in a subtest of our
study participants, the notable finding is that we do not see relations between BP variability
and cognitive function in those who have been successfully controlled. A parsimonious
explanation for these findings in unsuccessfully treated hypertensive individuals is that the
range of BP values was higher in this group of participants (range = 131–203 mmHg systolic
and 56–107 mmHg diastolic) than in the successfully medicated group (range = 87–140
mmHg systolic and 46–89 mmHg diastolic), thus allowing the variability relation to be
observed.
Importantly, statisically significant asociations between variability (or mean) and cognitive
measures were not obtained when only two measures of BP were employed. This is in
contrast to two other studies, both reporting associations between greater variability in
systolic BP, obtained from two sitting measures, and poorer performance on the MMSE.9,10
It seems logical that variability (SD) is less likely to be related to sensitive and specific
measures of cognitive performance when only two measurements of BP are obtained and the
present study indicates that more measurements are better than a few. Where two or fewer
measurements have been related to cognitive performance these measurements have been
averaged over multiple years of observation.30 Indeed Matsumoto et al.9 found weak
relations between two sitting office BP measurements and MMSE performance and
concluded their article by outlining the need for more assessments. Our finding of few
associations between varibility in performance and MMSE may relate to the different study
populations used in our study and by Matsumoto et al.9 As pointed out by Palatini,33 a
Japanese population may not be representative of non-Asian subjects and population-
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comparative studies are important. While ambulatory BP with multiple day-to-day measures
are an important source of data, especially eliminating white coat hypertension, our study
and others indicate that measure-to-measure variability (on the same day) in the office, the
clinic, or the research laboratory is a useful diagnostic tool with respect to cognitive
performance.
The pattern of results for the composite scores, especially for diastolic BP, is consistent with
a type of deficit in cognitive performance that can lead to vascular dementia.7,36 Working
memory and verbal memory were not related to variability in BP, but measures reflecting
executive function (Visual Spatial Memory and Organization) and abstract reasoning (the
Similarities Test) and Scanning and Tracking (Table 4 only) were related to variability and
mean BP. This is necessarily speculative but is consistent with the emphasis on vascular
brain injury as a mechanism related to cognitive deficit in relation to variability.33 Previous
investigations indicate that both short-term and long-term variability in BP are related to
white matter lesions, brain atrophy, and silent cerebral infarctions,12,37,38 but increased BP
variability could be the result of brain injury rather than the cause of it and high BP
variability may reflect underlying atherosclerotic processes.33 Clearly more research is
needed on the direction of the relation between BP variability and brain injury. However, we
speculate that the relations may be bidirectional and thus efforts to reduce variability should
be a clinical goal, at least until further studies have been done to clarify the direction of
relations between brain injury and BP pressure variability. Very clearly, efforts to reduce BP
variability should not be constrained to systolic BP.
Limitations
The study was cross-sectional and therefore any inference regarding the direction of the
relations between predictors and outcomes cannot be made, but it seems logical to speculate
that variability in BP is related to cognitive performance and that cognitive performance
does not produce variability in BP, especially when assessed following BP measurements.
Brain imaging was not performed in the present study. It is clear from the literature that
there are positive associations between higher BP variability and stuctural brain injury,
including cerebral microbleeds and white matter lesions,4,39 however it remains unclear as
to whether BP irregularity is a cause or consequence of brain changes. Palatini33 asks this
question and summarizes many mechanisms that may intervene between day-to-day BP
variability and vascular brain injury. This discussion applies equally well to measure-to-
measure variability which was the topic of our study.
Strengths
We have assessed relations between average BP and variability in BP, including both
systolic and diastolic measures, and cognitive function using an extensive
neuropsychological test battery measuring multiple cognitive domains as compared to one or
several measures. A completely unique aspect of the study is that we investigated BP
measures obtained in different postures, in addition to overall variability calculated from 15
repeated BP measurements. Finally, a novel aspect of this study was our stratified analyses
according to hypertension treatment status.
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Perspectives
The present study indicates that higher variability in both systolic and diastolic BP, obtained
from multiple measures taken at a single visit on the same day, are associated with poorer
cognitive performance in a sample including hypertensive and normotensive individuals,
especially in persons with unsuccessfully treated hypertension. This finding indicates the
potential importance of controlling variability in BP as well as averaged BP values. The
findings also highlight the benefits of more rather than fewer number of measurements of
BP given at a single occasion in a diagnostic, treatment or research context, especially when
dealing with uncontrolled BP levels. Very expensive and time consuming studies in terms of
data collection and controls for hypertension-related mortality and morbidity, have been
limited by one or two measurements of BP.7 Further, the relation of variability in BP to
cognition must include assessment of multiple cognitive abilities in order to determine
which cognitive domains are more vulnerable to cognitive deficits. Our studies suggest that
measures of executive function or fluid ability are related to BP variability. Trials examining
whether reducing BP variability, as well as mean levels of BP, can prevent or delay
cognitive decline are warranted and it will be important to determine whether variability
follows from brain injury, brain injury follows from variability, or whether relations are
bidirectional.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Novelty and Significance
1) What is new?
• First study to examine and compare associations between variability in BP taken
in different postures (sitting, reclining, lying), in addition to variability from all
measures, and cognitive function.
• First study to specifically examine associations between BP variability and
cognitive function in individuals being treated for hypertension, comparing
those with controlled versus uncontrolled hypertension.
• Cognitive function was assessed using multiple measures of cognitive domains
in addition to specific tests including the Mini-Mental State Examination.
2) What is relevant?
• Our study adds important data to the literature on BP variability and cognition.
• Studies evaluating the relationship between BP variability using office or clinic
measures and cognition to date have used few BP measures in the sitting
position, and have used one or a few cognitive tests.
• Studies have not examined variability in BP in relation to cognitive performance
for those with hypertension who are successfully treated and those who are not.
• While ambulatory BP with multiple measures has many diagnostic advantages,
multiple measurements in the laborory and office yield data as to relations
between variability in BP and cognition that are diagnostically important with
respect to cognitive performance.
• Where findings as to variability in BP have not been seen with measure-to-
measure variations in BP, too few BP assessments were undertaken and
restricted to the sitting position.
3) Summary
• Variability in sitting, reclining and standing diastolic BP was inversely related to
measures of cognitive performance, particularly executive function/fluid ability.
• Mean BP values were weaker predictors of cognition.
• Higher overall variability in both systolic and diastolic BP was associated with
poorer cognitive performance in unsuccessfully treated hypertensive individuals.
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